Literature DB >> 12082636

Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways.

H Oliver Weber1, Temesgen Samuel, Pia Rauch, Jens Oliver Funk.   

Abstract

The tumor suppressor ARF is transcribed from the INK4a/ARF locus in partly overlapping reading frames with the CDK inhibitor p16(Ink4a). ARF is able to antagonize the MDM2-mediated ubiquitination and degradation of p53, leading to either cell cycle arrest or apoptosis, depending on the cellular context. However, recent data point to additional p53-independent functions of mouse p19(ARF). Little is known about the dependency of human p14(ARF) function on p53 and its downstream genes. Therefore, we analysed the mechanism of p14(ARF)-induced cell cycle arrest in several human cell types. Wild-type HCT116 colon carcinoma cells (p53(+/+)p21(CIP1+/+) 14-3-3sigma(+/+)), but not p53(-/-) counterparts, underwent G(1) and G(2) cell cycle arrest following infection with a p14(ARF)-adenovirus. In p21(CIP1-/-) cells, p14(ARF) did not induce G(1) or G(2) arrest, while 14-3-3sigma(-/-) counterparts were mainly arrested in G(1), pointing to essential roles of p21(CIP1) in G(1) and G(2) arrest and cooperative roles of p21 and 14-3-3sigma in ARF-mediated G(2) arrest. Our data demonstrate a strict p53 and p21(CIP1) dependency of p14(ARF)-induced cell cycle arrest in human cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082636     DOI: 10.1038/sj.onc.1205429

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

Review 1.  Molecular Mechanisms of Arsenic-Induced Disruption of DNA Repair.

Authors:  Lok Ming Tam; Nathan E Price; Yinsheng Wang
Journal:  Chem Res Toxicol       Date:  2020-02-07       Impact factor: 3.739

2.  P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3.

Authors:  Abdessamad Zerrouqi; Beata Pyrzynska; Maria Febbraio; Daniel J Brat; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 3.  Obstacles to Translating Genotype-Phenotype Correlates in Metabolic Disease.

Authors:  Anu Sharma; Adrian Vella
Journal:  Physiology (Bethesda)       Date:  2017-01

Review 4.  The p53 tumor suppressor protein regulates hematopoietic stem cell fate.

Authors:  Takashi Asai; Yan Liu; Narae Bae; Stephen D Nimer
Journal:  J Cell Physiol       Date:  2011-09       Impact factor: 6.384

5.  Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis.

Authors:  Seema Paliwal; Sandhya Pande; Ramesh C Kovi; Norman E Sharpless; Nabeel Bardeesy; Steven R Grossman
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

6.  Beryllium sulfate induces p21 CDKN1A expression and a senescence-like cell cycle arrest in susceptible cancer cell types.

Authors:  Priyatham Gorjala; Ronald K Gary
Journal:  Biometals       Date:  2010-06-12       Impact factor: 2.949

7.  Valproate inhibits colon cancer growth through cell cycle modification in vivo and in vitro.

Authors:  Christoph W Strey; Lea Schamell; Elsie Oppermann; Axel Haferkamp; Wolf O Bechstein; Roman A Blaheta
Journal:  Exp Ther Med       Date:  2011-01-20       Impact factor: 2.447

8.  P14ARF suppresses tumor-induced thrombosis by regulating the tissue factor pathway.

Authors:  Abdessamad Zerrouqi; Beata Pyrzynska; Daniel J Brat; Erwin G Van Meir
Journal:  Cancer Res       Date:  2014-01-07       Impact factor: 12.701

Review 9.  Aberrant crypt foci as precursors in colorectal cancer progression.

Authors:  Frank A Orlando; Dongfeng Tan; Juan D Baltodano; Thaer Khoury; John F Gibbs; Victor J Hassid; Bestoun H Ahmed; Sadir J Alrawi
Journal:  J Surg Oncol       Date:  2008-09-01       Impact factor: 3.454

10.  Loss-of-Function Mutations in the Cell-Cycle Control Gene CDKN2A Impact on Glucose Homeostasis in Humans.

Authors:  Aparna Pal; Thomas P Potjer; Soren K Thomsen; Hui Jin Ng; Amy Barrett; Raphael Scharfmann; Tim J James; D Timothy Bishop; Fredrik Karpe; Ian F Godsland; Hans F A Vasen; Julia Newton-Bishop; Hanno Pijl; Mark I McCarthy; Anna L Gloyn
Journal:  Diabetes       Date:  2015-11-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.